July 26, 2022 02:40 PM EDT
FDA+
Manufacturing

St. Louis-based API man­u­fac­tur­er slammed with FDA warn­ing let­ter over 'per­va­sive mold,' qual­i­ty is­sues

Zachary Brennan

Senior Editor

The growth of API man­u­fac­tur­ing in In­dia and Chi­na has led to nu­mer­ous warn­ing let­ters and lots of ques­tion marks around qual­i­ty con­trol and da­ta …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times